(Q40375140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Tetsuya Hosaka

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

13

Hiromitsu Kumada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

3

Fumitaka Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

12

Kenji Ikeda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

7

Masahiro Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

10

Yoshiyuki Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

11

Yasuji Arase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

2

Hitomi Sezaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

9

Satoshi Saitoh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

5

Yusuke Kawamura

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

8

Mariko Kobayashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

4

Shunichiro Fujiyama

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

publication date

27 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

9 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

page(s)

1248-1254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

9 April 2020

cites work

1 reference

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

21 January 2018

1 reference

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

21 January 2018

1 reference

Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial

21 January 2018

1 reference

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

21 January 2018

1 reference

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan.

21 January 2018

1 reference

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

21 January 2018

1 reference

Virological escape in HCV genotype-1-infected patients receiving daclatasvir plus ribavirin and peginterferon alfa-2a or alfa-2b

21 January 2018

1 reference

Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens

21 January 2018

1 reference

The importance of resistance to direct antiviral drugs in HCV infection in clinical practice

21 January 2018

1 reference

Rapid single-colony whole-genome sequencing of bacterial pathogens

21 January 2018

1 reference

In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir

21 January 2018

1 reference

Real-world effectiveness of ledipasvir/sofosbuvir in 4,365 treatment-naive, genotype 1 hepatitis C-infected patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.24767

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28079269%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference